Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXTEND International: Extending the Time for Thrombolysis in Emergency Neurological Deficits
2014-002864-33Phase 3Terminated
- Sponsor
- Florey Institute of Neuroscience and Mental Health
- Start
- Nov 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ischemic stroke comparing Alteplase with Placebo (2 arms). Primary endpoint: Functional independence at 90 days. Started Nov 2014; status: terminated.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2014-002864-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002864-33.